PMV Pharmaceuticals PMVP

$ 1.6 -0.8%

Quarterly report 2024-Q3
added 11-07-2024

PMV Pharmaceuticals Financial Statements 2011-2024 | PMVP

Annual Financial Statements PMV Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	88.3 M	280 M	715 M	541 M	-	-	-	-	-	-	-	-	-
Shares	48 M	45.6 M	45.1 M	14.4 M	-	-	-	-	-	-	-	-	-
Historical Prices	1.84	6.15	15.8	37.6	-	-	-	-	-	-	-	-	-
Net Income	-69 M	-73.3 M	-57.8 M	-34.4 M	-25.4 M	-17.5 M	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-80.1 M	-77 M	-58.3 M	-34.9 M	-26.6 M	-18.9 M	-	-	-	-	-	-	-
Interest Expense	11.2 M	3.71 M	470 K	508 K	1.29 M	1.36 M	-	-	-	-	-	-	-
EBITDA	-78.9 M	-76.7 M	-58 M	-34.6 M	-26.2 M	-18.6 M	-	-	-	-	-	-	-
Operating Expenses	80.1 M	77 M	58.3 M	34.9 M	26.6 M	18.9 M	-	-	-	-	-	-	-
General and Administrative Expenses	24.2 M	25.1 M	21.8 M	11 M	5.88 M	5.04 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement PMV Pharmaceuticals

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	51.6 M	51.5 M	51.4 M	49 M	45.8 M	45.8 M	45.8 M	45.6 M	45.6 M	45.5 M	45.4 M	45.3 M	45.1 M	44.8 M	44.8 M	6.02 M	3.05 M	3.05 M	3.05 M	3.05 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-19.2 M	-1.21 M	-	-16.6 M	-17.4 M	-19.1 M	-	-18.2 M	-17.3 M	-18.4 M	-	-15 M	-12.9 M	-11.6 M	-	-8.76 M	-7.97 M	-7.26 M	-	-6.18 M	-6.13 M	-6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-21.9 M	-20.2 M	-	-19.6 M	-20.1 M	-21.5 M	-	-19.4 M	-17.9 M	-18.6 M	-	-15.1 M	-13 M	-11.7 M	-	-8.7 M	-8.08 M	-7.65 M	-	-6.44 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	2.74 M	2.78 M	-	2.99 M	2.69 M	2.35 M	-	1.14 M	573 K	188 K	-	105 K	176 K	76 K	-	-60 K	118 K	401 K	-	272 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-21.5 M	-19.8 M	-	-19.3 M	-19.8 M	-21.3 M	-	-19.3 M	-17.8 M	-18.5 M	-	-15 M	-13 M	-11.6 M	-	-8.63 M	-8 M	-7.56 M	-	-6.33 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	21.9 M	20.2 M	-	19.6 M	20.1 M	21.5 M	-	19.4 M	17.9 M	18.6 M	-	15.1 M	13 M	11.7 M	-	8.7 M	8.08 M	7.65 M	-	6.44 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	4.94 M	5.54 M	-	6.04 M	6.28 M	6.41 M	-	5.71 M	6.42 M	6.78 M	-	5.94 M	5.39 M	4.17 M	-	2.71 M	2.28 M	1.7 M	-	1.54 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency